These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8213583)

  • 81. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group.
    van Boven AJ; Jukema JW; Zwinderman AH; Crijns HJ; Lie KI; Bruschke AV
    Circulation; 1996 Oct; 94(7):1503-5. PubMed ID: 8840836
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE).
    Sacks FM; Pfeffer MA; Moye' L; Brown LE; Hamm P; Cole TG; Hawkins CM; Braunwald E
    Am J Cardiol; 1991 Dec; 68(15):1436-46. PubMed ID: 1746424
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.
    Jacobson TA; Chin MM; Curry CL; Miller V; Papademetriou V; Schlant RC; LaRosa JC
    Arch Intern Med; 1995 Sep; 155(17):1900-6. PubMed ID: 7677557
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. The West of Scotland Coronary Prevention Study Group.
    Am J Cardiol; 1997 Mar; 79(6):756-62. PubMed ID: 9070554
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
    Crouse JR; Byington RP; Bond MG; Espeland MA; Craven TE; Sprinkle JW; McGovern ME; Furberg CD
    Am J Cardiol; 1995 Mar; 75(7):455-9. PubMed ID: 7863988
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension.
    Straznicky NE; Howes LG; Lam W; Louis WJ
    Am J Cardiol; 1995 Mar; 75(8):582-6. PubMed ID: 7887382
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of hyperlipidemia in the nephrotic syndrome: the effects of pravastatin therapy.
    Spitalewitz S; Porush JG; Cattran D; Wright N
    Am J Kidney Dis; 1993 Jul; 22(1):143-50. PubMed ID: 8322777
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Does lowering of cholesterol levels influence functional properties of large arteries?
    Kool M; Lustermans F; Kragten H; Struijker Boudier H; Hoeks A; Reneman R; Rila H; Hoogendam I; Van Bortel L
    Eur J Clin Pharmacol; 1995; 48(3-4):217-23. PubMed ID: 7589044
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A coronary primary prevention study of Scottish men aged 45-64 years: trial design. The West of Scotland Coronary Prevention Study Group.
    J Clin Epidemiol; 1992 Aug; 45(8):849-60. PubMed ID: 1624967
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study).
    Nakaya N; Mizuno K; Ohashi Y; Teramoto T; Yokoyama S; Hirahara K; Mizutani M; Nakamura H;
    Drugs Aging; 2011 Sep; 28(9):681-92. PubMed ID: 21815708
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Serum triglycerides predict first cardiovascular events in diabetic patients with hypercholesterolemia and retinopathy.
    Tada H; Kawashiri MA; Nomura A; Yoshimura K; Itoh H; Komuro I; Yamagishi M
    Eur J Prev Cardiol; 2018 Nov; 25(17):1852-1860. PubMed ID: 30160521
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin.
    West MJ; White HD; Simes RJ; Kirby A; Watson JD; Anderson NE; Hankey GJ; Wonders S; Hunt D; Tonkin AM
    J Hypertens; 2002 Dec; 20(12):2513-7. PubMed ID: 12473877
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The management of hypercholesterolaemia in patients with coronary artery disease referred for coronary angiography.
    Saia F; Chua TP; Fox KM
    Int J Cardiol; 1998 Dec; 67(3):247-9. PubMed ID: 9894706
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study.
    Sato H; Kinjo K; Ito H; Hirayama A; Nanto S; Fukunami M; Nishino M; Lim YJ; Kijima Y; Koretsune Y; Nakatani D; Mizuno H; Shimizu M; Hori M;
    Circ J; 2008 Jan; 72(1):17-22. PubMed ID: 18159093
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of pravastatin on proteinuria in patients with well-controlled hypertension.
    Lee TM; Su SF; Tsai CH
    Hypertension; 2002 Jul; 40(1):67-73. PubMed ID: 12105140
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study.
    Am J Cardiol; 1995 Sep; 76(7):485-91. PubMed ID: 7653449
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation.
    Bairey Merz CN; Felando MN; Klein J
    J Cardiopulm Rehabil; 1996; 16(2):117-22. PubMed ID: 8681156
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pravastatin, lipids, and major coronary events.
    Furberg CD; Byington RP; Crouse JR; Espeland MA
    Am J Cardiol; 1994 Jun; 73(15):1133-4. PubMed ID: 8198043
    [No Abstract]   [Full Text] [Related]  

  • 99. Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I).
    Pitt B; Ellis SG; Mancini GB; Rosman HS; McGovern ME
    Am J Cardiol; 1993 Jul; 72(1):31-5. PubMed ID: 8517425
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cholesterol-lowering effects of bovine serum immunoglobulin in participants with mild hypercholesterolemia.
    Earnest CP; Jordan AN; Safir M; Weaver E; Church TS
    Am J Clin Nutr; 2005 Apr; 81(4):792-8. PubMed ID: 15817854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.